BG9588
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for BG9588, covering 2008-03-04 to 2008-03-04. Get the full timeline:
Most recent: Clinical Trial Update: Study Comparing the Safety of BG9588 (Anti-CD40L Antibody) Against Standard Treatment in Kidney Transplantation [Phase 2]